In Ohio, the Cleveland Clinic joined the Circulating Cell-free Genome Atlas, a national clinical trial that is looking for 7,000 cancer patients and 3,000 healthy patients in the U.S. Their goal is to analyze DNA and RNA in the blood and build a database that will help with detecting cancer early on when it is easier to cure. Researchers believe that using genome sequencing from blood samples could possibly replace x-rays for early cancer detection. Funded by a company in California, GRAIL, Inc., the project will be looking for molecule patterns in the blood for specific types of cancers.
Latest article
From larvae to laundry: Sasol introduces insect oil-based surfactant
In Houston, Sasol has introduced a surfactant made from oil obtained from black soldier fly larvae.
Trade named LIVINEX IO 7, the insect-based surfactant meets...
Fungi fix: Dutch designer Dierkx shows mycelium can convert waste plastic into protein bars
In the Netherlands, designer Odette Dierkx has envisioned a new concept for producing protein bars: dried mycelium that has been fed waste plastics.
Dubbed...
Green toilet clean: Henkel taps LyondellBasell for biobased toilet cleaner packaging
In Germany, cleaning products giant Henkel is using biobased plastic from Houston’s LyondellBasell in its toilet cleaner packaging.
The packaging will specifically use LyondellBasell’s...